Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062993-09-004536
Filing Date
2009-12-24
Accepted
2009-12-24 16:46:16
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE YEAR ENDED SEPTEMBER 30, 2009 form10k.htm 10-K 562566
2 SECTION 302 CERTIFICATION - CEO exhibit31-1.htm EX-31.1 6558
3 SECTION 302 CERTIFICATION - CFO exhibit31-2.htm EX-31.2 6634
4 SECTION 906 CERTIFICATION - CEO exhibit32-1.htm EX-32.1 2443
5 SECTION 906 CERTIFICATION - CFO exhibit32-2.htm EX-32.2 2480
  Complete submission text file 0001062993-09-004536.txt   582225
Mailing Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000
Business Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000 30-210-603-4026
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-51652 | Film No.: 091260478
SIC: 8731 Services-Commercial Physical & Biological Research